Bank of New York Mellon’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $114M | Sell |
|
|||||
|
2025
Q1 | $131M | Sell |
|
|||||
|
2024
Q4 | $149M | Sell |
|
|||||
|
2024
Q3 | $194M | Sell |
|
|||||
|
2024
Q2 | $289M | Sell |
|
|||||
|
2024
Q1 | $297M | Sell |
|
|||||
|
2023
Q4 | $360M | Sell |
|
|||||
|
2023
Q3 | $368M | Sell |
|
|||||
|
2023
Q2 | $419M | Sell |
|
|||||
|
2023
Q1 | $410M | Sell |
|
|||||
|
2022
Q4 | $419M | Buy |
|
|||||
|
2022
Q3 | $402M | Sell |
|
|||||
|
2022
Q2 | $314M | Buy |
|
|||||
|
2022
Q1 | $303M | Sell |
|
|||||
|
2021
Q4 | $352M | Sell |
|
|||||
|
2021
Q3 | $456M | Sell |
|
|||||
|
2021
Q2 | $611M | Sell |
|
|||||
|
2021
Q1 | $609M | Buy |
|
|||||
|
2020
Q4 | $525M | Sell |
|
|||||
|
2020
Q3 | $656M | Sell |
|
|||||
|
2020
Q2 | $620M | Sell |
|
|||||
|
2020
Q1 | $763M | Buy |
|
|||||
|
2019
Q4 | $628M | Buy |
|
|||||
|
2019
Q3 | $440M | Buy |
|
|||||
|
2019
Q2 | $404M | Sell |
|
|||||
|
2019
Q1 | $446M | Sell |
|
|||||
|
2018
Q4 | $673M | Sell |
|
|||||
|
2018
Q3 | $813M | Sell |
|
|||||
|
2018
Q2 | $686M | Buy |
|
|||||
|
2018
Q1 | $627M | Sell |
|
|||||
|
2017
Q4 | $762M | Buy |
|
|||||
|
2017
Q3 | $728M | Buy |
|
|||||
|
2017
Q2 | $509M | Sell |
|
|||||
|
2017
Q1 | $557M | Buy |
|
|||||
|
2016
Q4 | $573M | Sell |
|
|||||
|
2016
Q3 | $683M | Sell |
|
|||||
|
2016
Q2 | $569M | Sell |
|
|||||
|
2016
Q1 | $701M | Sell |
|
|||||
|
2015
Q4 | $865M | Sell |
|
|||||
|
2015
Q3 | $938M | Buy |
|
|||||
|
2015
Q2 | $1.25B | Sell |
|
|||||
|
2015
Q1 | $1.36B | Sell |
|
|||||
|
2014
Q4 | $1.14B | Buy |
|
|||||
|
2014
Q3 | $1.1B | Buy |
|
|||||
|
2014
Q2 | $1.01B | Sell |
|
|||||
|
2014
Q1 | $995M | Buy |
|
|||||
|
2013
Q4 | $832M | Sell |
|
|||||
|
2013
Q3 | $735M | Buy |
|
|||||
|
2013
Q2 | $605M | Buy |
|